Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- Check5 days agoChange DetectedFooter Revision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check13 days agoChange DetectedDuke Eye Center in Durham, NC was added to the study locations, bringing the total sites to 17 and the recruitment status to Recruiting.SummaryDifference0.5%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdministrative updates show new update dates in February 2026 (2026-02-17, 2026-02-13, 2026-02) and corresponding deletions from January 2026 (2026-01-15, 2026-01-14, 2026-01). There is no evidence of changes to the study design, endpoints, eligibility criteria, enrollment, or recruitment locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site now displays Revision: v3.4.2, and the funding-status notice as well as the previous Revision: v3.4.1 text have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide government funding notice was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedA glossary toggle was added and some page metadata text was updated or removed (e.g., Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.